For research use only
| Cat No. | ABC-X0047C |
| Product Type | Overexpression Stable Cell Lines |
| Cell Type | Fibroblast |
| Species | Human |
| Host Cell | NIH/3T3 |
| Source Organ | Embryo |
| Disease | Normal |
| Storage | Liquid Nitrogen |
The BRAF (L597Q) NIH/3T3 cell line is a powerful tool for investigating tumor mechanisms, supporting targeted drug screening and resistance analysis.
Human BRAF (L597Q) NIH/3T3 Cell Line is a genetically engineered model derived from murine NIH/3T3 fibroblast cells based on customers’ requirement. BRAF (L597Q) NIH/3T3 mutant cell line is developed through stable lentiviral-mediated integration of the human BRAF gene containing the L597Q mutation.
Target
The L597Q mutation in BRAF lies adjacent to the activation segment of the kinase domain and leads to enhanced dimerization and increased downstream MEK/ERK pathway activation. It is recurrently observed in melanoma and other solid tumors, particularly in non-V600E mutant contexts. AcceGen specializes in generation of BRAF-mutant cell lines for oncogenic mechanism studies. Polyclonal or monoclonal is optional based on customers’ research needs.
| Species | Human |
| Cat.No | ABC-X0047C |
| Product Category | Transfected Stable Cell Lines |
| Size/Quantity | 1 vial |
| Cell Type | Fibroblast |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 °C, 5% CO₂ |
| Source Organ | Embryo |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Overexpression Stable Cell Lines |
| Host Cell | NIH/3T3 |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
The BRAF (L597Q) NIH/3T3 Cell Line provides a potent tool to explore BRAF dimerization, mutation-specific signaling, and therapeutic vulnerabilities. It supports targeted drug screening, resistance analysis, and functional cancer genomics.